Hydroxocobalamin and Hyponatremia - a phase IV clinical study of FDA data
Hyponatremia is found among people who take Hydroxocobalamin, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Hydroxocobalamin and have Hyponatremia. It is created by eHealthMe based on reports of 3,048 people who have side effects when taking Hydroxocobalamin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
3,048 people reported to have side effects when taking Hydroxocobalamin.
Among them, 146 people (4.79%) have Hyponatremia.
What is Hydroxocobalamin?
Hydroxocobalamin has active ingredients of hydroxocobalamin. It is often used in pernicious anaemia. eHealthMe is studying from 3,423 Hydroxocobalamin users for its effectiveness, alternative drugs and more.
What is Hyponatremia?
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration) is found to be associated with 2,562 drugs and 1,368 conditions by eHealthMe.
Number of Hydroxocobalamin and Hyponatremia reports submitted per year:
Time on Hydroxocobalamin when people have Hyponatremia *:
Gender of people who have Hyponatremia when taking Hydroxocobalamin*:
Age of people who have Hyponatremia when taking Hydroxocobalamin *:
Common drugs people take besides Hydroxocobalamin *:
Common side effects people have besides Hyponatremia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Hydroxocobalamin and have Hyponatremia?Check whether Hyponatremia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Choi N, Lee JY, Sunwoo JS, Kwon KI, Roh H, Ahn MY, Lee KB, "Hyponatremia during Acyclovir Treatment of Bell’s Palsy", Journal of the Korean Neurological Association, 2017 Aug .
- Koza Y, Ta? MH, ?im?ek Z, Gündo?du F, "Hyponatremia and heart failure: the overlooked piece of the puzzle", Anatolian journal of cardiology, 2016 Jan .
- Das S, Bandyopadhyay S, Ramasamy A, Prabhu VV, Pachiappan S, "A case of losartan-induced severe hyponatremia", Journal of pharmacology & pharmacotherapeutics, 2015 Jan .
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Kate N, Grover S, Kumar S, Modi M, "Bupropion-induced hyponatremia", General hospital psychiatry, 2013 Dec .
How severe was Hyponatremia and when was it recovered:
Expand to all the drugs that have ingredients of hydroxocobalamin:
Alternative drugs to, pros and cons of Hydroxocobalamin:
- Hydroxocobalamin (3,423 reports)
Common Hydroxocobalamin side effects:
Browse all side effects of Hydroxocobalamin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Hyponatremia treatments and more:
- Hyponatremia (64,916 reports)
COVID vaccines that are related to Hyponatremia:
- Hyponatremia in Moderna COVID Vaccine
- Hyponatremia in Pfizer BioNTech Covid Vaccine
- Hyponatremia in Johnson and Johnson Covid Vaccine
Common drugs associated with Hyponatremia:
All the drugs that are associated with Hyponatremia:
- Hyponatremia (2,562 drugs)
Common conditions associated with Hyponatremia:
All the conditions that are associated with Hyponatremia:
- Hyponatremia (1,368 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on hydroxocobalamin (the active ingredients of Hydroxocobalamin) and Hydroxocobalamin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Alavert and Reyataz drug interaction - a second ago
- Cyclosporine and Thrombocytosis - 5 seconds ago
- Trifluoperazine Hcl and Pancreatitis - 7 seconds ago
- Ocupress and Hallucinations - 7 seconds ago
- Vx-950 and Seroquel Xr drug interaction - 8 seconds ago
- St. John'S Wort and Hyperhidrosis - 13 seconds ago
- Cetirizine Hydrochloride and Letairis drug interaction - 16 seconds ago
- Firazyr and Tylenol drug interaction - 17 seconds ago
- Prochlorperazine Maleate and Metastases To Liver - 22 seconds ago
- Folic Acid and Carotid Pulse Abnormal - 25 seconds ago